Search U.S. Product Recalls Database

Showing 14801–14820 of 15081 results

Sort:

Paclitaxel Injection (Hospira) – Visibility Issue (2012)

The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.

Class IIModerate

FDAJun 27, 2012Nationwide• Hospira Inc.

Cytarabine Injection (Hospira) – Visibility Issue (2012)

Class II

Stay Informed

Search Product Recalls

Paclitaxel Injection (Hospira) – Visibility Issue (2012)

Cytarabine Injection (Hospira) – Visibility Issue (2012)

Vecuronium Bromide Injection (Ben Venue) – Particulate Matter (2012)

Oxygen Compressed Gas (Oklahoma Respiratory) – CGMP Testing Issues (2012)

Lactated Ringer's Injection (Hospira) – CGMP Deviations (2012)

Tobramycin Ophthalmic Ointment (Stat Rx) – Labeling Mixup (2012)

PROTEAN Lean Protein (iForce Nutrition) – Undeclared Wheat (2012)

Sienna Bakery Oatmeal Walnut Cookies (Best Maid) – Voluntary Withdrawal (2012)

Erythromycin Topical Solution (Fougera) – Chemical Contamination (2012)

Diazepam Injection (Meridian Medical) – Impurity Contamination (2012)

Kombiglyze XR (Bristol-Myers) – Mislabeled Samples (2012)

Kombiglyze XR (Bristol-Myers) – Mislabeled Samples (2012)

Pitocin Injection (JHP Pharmaceuticals) – Labeling Error (2012)

Caziant Tablets (Watson Labs) – Impurity Issues (2012)

Trizivir Tablets (GlaxoSmithKline) – Tablet Contamination (2012)

Digestive Supplement (Botanical Labs) – Salmonella Risk (2012)

Cardiogen-82 (Bracco Diagnostics) – Sr-82 level deviation (2012)

Leukine Sargramostim (Bayer) – impurity at 3 months (2012)

Hydrocodone Acetaminophen Solution (VistaPharm) – stability issue (2012)

Diclofenac Sodium Injectable (Franck's Lab) – Sterility Concerns (2012)